NCT04549935View on ClinicalTrials.gov

The PRIME Study: A Randomized, Controlled, Prospective Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

August 27, 2021

Study Completion Date

August 27, 2021

Conditions
Patient PreferencePatient OutcomesPost-Operative InflammationGrade of Post-Operative Cystoid Macular EdemaRate of Post-Operative Cystoid Macular Edema
Interventions
DRUG

Dextenza

Dextenza 0.4mg

DRUG

Topical Prednisolone

Standard of care topical drop treatment

Trial Locations (1)

59718

RECRUITING

Briana Parker, Bozeman

All Listed Sponsors
lead

Vance Thompson Vision - MT

OTHER